The benefit of screening for prostate cancer using prostate-specific antigen ( PSA ) testing and digital rectal examination ( DRE ) is uncertain and is under evaluation in a randomized prospective trial , the Prostate , Lung , Colorectal and Ovarian ( PLCO ) Cancer Screening Trial .
